{"schema_version":"secwatch.filing_event.v1","accession":"0001062993-25-013266","form_type":"8-K","ticker":"MDCX","cik":"0001997296","company_name":"Medicus Pharma Ltd.","filed_at":"2025-07-30T23:59:59+00:00","discovered_at":"2026-05-14T18:02:45.781659+00:00","generated_at":"2026-05-17T23:13:15.565011+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Medicus Pharma hires Deloitte to find out-licensing partner for D-MNA (BCC)","bullets":["Deloitte appointed exclusive lead financial adviser for out-licensing D-MNA for basal cell carcinoma.","Company will pay Deloitte retainer plus contingent success fee if a transaction closes.","Engagement letter signed July 29, 2025; no partner identified yet."],"urls":{"canonical":"https://secwatch.observer/filing/0001062993-25-013266","json":"https://secwatch.observer/filing/0001062993-25-013266.json","markdown":"https://secwatch.observer/filing/0001062993-25-013266.md","text":"https://secwatch.observer/filing/0001062993-25-013266.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1997296/000106299325013266/0001062993-25-013266-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1997296/000106299325013266/form8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T23:13:15.565011+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}